AN UNBIASED VIEW OF GR 113808

quinupristin/dalfopristin increases levels of erythromycin lactobionate by reducing metabolism. Contraindicated. Threat of extended QTc interval.Keep an eye on Closely (1)quinupristin/dalfopristin will raise the stage or outcome of mavorixafor by affecting hepatic/intestinal enzyme CYP3A4 metabolism.When you are obtaining this medicine, it is parti